Journal of Clinical & Experimental Immunology(JCEI)
ISSN: 2475-6296 | DOI: 10.33140/JCEI
Impact Factor: 1.9
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
mAb Therapeutics Approved by FDA for Hematologic Malignancies (Mini Review)
Citation
Henry Hongrong Cai and Ayesha A. Pandit
Henry Hongrong Cai, MD* and Ayesha A. Pandit, MD MS (2023) mAb Therapeutics Approved by FDA for Hematologic Malignancies (Mini Review). J Clin Exp Immunol. 8(1); 530-532.